ctrl K

Bright Minds Biosciences ... (DRUG)

NASDAQ: DRUG · Real-Time Price · USD

32.11

1.49 (4.87%)

At close: May 02, 2025, 3:01 PM

Bright Minds Biosciences Balance Sheet Statement

Financials in CAD. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Cash & Equivalents	5.72M	6.75M	11.63M	19.76M	799.93K	79.99K
Short-Term Investments	n/a	86.25K	86.25K	86.25K	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	33.68K	1K	81.98K
Other Long-Term Assets	n/a	n/a	-0.00	-33.68K	-1K	n/a
Receivables	n/a	n/a	155.78K	110.15K	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	5.99M	6.81M	11.95M	20.04M	878.22K	79.99K
Property-Plant & Equipment	117.66K	66.41K	138.86K	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	2K	2K	2K
Total Long-Term Assets	117.66K	66.41K	138.86K	2K	2K	83.98K
Total Assets	6.1M	6.88M	12.09M	20.04M	880.22K	163.97K
Account Payables	407.55K	182.31K	1.25M	596.57K	138.42K	36.71K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	528.68K	280.86K	1.47M	638.57K	150.92K	36.71K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	39.58K	n/a	71.98K	n/a	n/a	n/a
Total Liabilities	568.26K	280.86K	1.54M	638.57K	150.92K	36.71K
Total Debt	118.96K	73.55K	139.91K	n/a	n/a	n/a
Common Stock	35.42M	33.91M	32.24M	27.08M	980.66K	205.98K
Retained Earnings	-34.35M	-31.55M	-24.17M	-9.21M	-559.09K	-78.72K
Comprehensive Income	4.01M	3.4M	2.48M	1.57M	161.3K	-81.98K
Shareholders Equity	5.54M	6.6M	10.54M	19.4M	729.29K	127.26K
Total Investments	n/a	86.25K	86.25K	119.93K	1K	81.98K